Remarkable alkaline stability of an engineered protein A as immunoglobulin affinity ligand: C domain having only one amino acid substitution |
| |
Authors: | Kazunobu Minakuchi Dai Murata Yuji Okubo Yoshiyuki Nakano Shinichi Yoshida |
| |
Institution: | Frontier Biochemical and Medical Research Laboratories, Kaneka Corp., , 676‐8688 Japan |
| |
Abstract: | Protein A affinity chromatography is the standard purification process for the capture of therapeutic antibodies. The individual IgG‐binding domains of protein A (E, D, A, B, C) have highly homologous amino acid sequences. From a previous report, it has been assumed that the C domain has superior resistance to alkaline conditions compared to the other domains. We investigated several properties of the C domain as an IgG‐Fc capture ligand. Based on cleavage site analysis of a recombinant protein A using a protein sequencer, the C domain was found to be the only domain to have neither of the potential alkaline cleavage sites. Circular dichroism (CD) analysis also indicated that the C domain has good physicochemical stability. Additionally, we evaluated the amino acid substitutions at the Gly‐29 position of the C domain, as the Z domain (an artificial B domain) acquired alkaline resistance through a G29A mutation. The G29A mutation proved to increase the alkaline resistance of the C domain, based on BIACORE analysis, although the improvement was significantly smaller than that observed for the B domain. Interestingly, a number of other amino acid mutations at the same position increased alkaline resistance more than did the G29A mutation. This result supports the notion that even a single mutation on the originally alkali‐stable C domain would improve its alkaline stability. An engineered protein A based on this C domain is expected to show remarkable performance as an affinity ligand for immunoglobulin. |
| |
Keywords: | protein engineering IgG‐binding domain therapeutic antibody affinity ligand physicochemical stability |
|
|